Peer Review History
| Original SubmissionJuly 2, 2024 |
|---|
|
PONE-D-24-27060Oral supplementation of Lactobacillus plantarum KAD Prevents High-Fat Diet-Induced Hepatic Complications in Swiss Albino Mice: Role of Inflammation and Gut IntegrityPLOS ONE Dear Dr. Saha, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Oct 05 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Ahmed Khalafallah Sadeq Rashwan, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. To comply with PLOS ONE submissions requirements, in your Methods section, please provide additional information regarding the experiments involving animals and ensure you have included details on (1) methods of sacrifice, (2) methods of anesthesia and/or analgesia, and (3) efforts to alleviate suffering. 3. Thank you for stating the following in your Competing Interests section: On behalf of all authors I disclose that there is no competing interests that could be perceived to bias this work. Please complete your Competing Interests on the online submission form to state any Competing Interests. If you have no competing interests, please state ""The authors have declared that no competing interests exist."", as detailed online in our guide for authors at http://journals.plos.org/plosone/s/submit-now This information should be included in your cover letter; we will change the online submission form on your behalf. 4. We note that your Data Availability Statement is currently as follows: All relevant data are within the manuscript and its Supporting Information files. Please confirm at this time whether or not your submission contains all raw data required to replicate the results of your study. Authors must share the “minimal data set” for their submission. PLOS defines the minimal data set to consist of the data required to replicate all study findings reported in the article, as well as related metadata and methods (https://journals.plos.org/plosone/s/data-availability#loc-minimal-data-set-definition). For example, authors should submit the following data: - The values behind the means, standard deviations and other measures reported; - The values used to build graphs; - The points extracted from images for analysis. Authors do not need to submit their entire data set if only a portion of the data was used in the reported study. If your submission does not contain these data, please either upload them as Supporting Information files or deposit them to a stable, public repository and provide us with the relevant URLs, DOIs, or accession numbers. For a list of recommended repositories, please see https://journals.plos.org/plosone/s/recommended-repositories. If there are ethical or legal restrictions on sharing a de-identified data set, please explain them in detail (e.g., data contain potentially sensitive information, data are owned by a third-party organization, etc.) and who has imposed them (e.g., an ethics committee). Please also provide contact information for a data access committee, ethics committee, or other institutional body to which data requests may be sent. If data are owned by a third party, please indicate how others may request data access. Additional Editor Comments (if provided): This manuscript number (PONE-D-24-27060) is entitled "Oral supplementation of Lactobacillus plantarum KAD Prevents High-Fat Diet-Induced Hepatic Complications in Swiss Albino Mice: Role of Inflammation and Gut Integrity". The novelty of the manuscript is good although the analyses are not sufficient in this work. This article can be considered for publication after doing the following major revisions: 1. This paper is worthy of publication although the novelty should be addressed clearly in the abstract and introduction 2. The abstract is concise but could benefit from a clearer statement of the study's objectives, methods, main findings, and significance. Start by clearly stating the objective of the study. Briefly describe the methodology, emphasizing the study design and key experimental procedures. Highlight the most significant results, particularly those that demonstrate the impact of Lactobacillus plantarum KAD on hepatic complications. Conclude with a sentence on the study’s implications for future research or clinical practice. 3. The introduction outlines the background and the need for the study but could be more focused on the research gap. Streamline the introduction by focusing on the specific gaps in current research that your study addresses. For instance, emphasize the novelty of exploring Lactobacillus plantarum KAD’s role in hepatic complications within the context of high-fat diet-induced obesity. You might also want to more explicitly state the hypothesis or primary research question. 4. The methods are detailed, but some sections might be too dense. Consider breaking down the methods into more specific subheadings for clarity, such as "Animal Grouping and Diet," "Biochemical Analysis," "Histological Examination," etc. This will make it easier for readers to follow your procedures. Additionally, ensure that all procedures, especially those involving statistical analyses, are described with enough detail to allow replication. 5. The results section is comprehensive but could benefit from more emphasis on the significance of the findings. Instead of just presenting the data, you can enhance the narrative by linking the findings back to the research questions. For instance, when discussing the lipid profile or histological findings, briefly state what these results imply about the effectiveness of Lactobacillus plantarum KAD. Use subheadings to organize the results logically, perhaps under themes like "Glycemic Control," "Lipid Metabolism," "Hepatic Function," etc. 6. The discussion provides a good analysis but can be more tightly linked to the results. Start by summarizing the main findings in a few sentences. Then, critically evaluate these findings in the context of existing literature, discussing how your study confirms, contradicts, or extends previous research. Ensure that the discussion logically follows from the results presented, addressing potential limitations of the study and suggesting areas for future research. Consider framing the discussion around how Lactobacillus plantarum KAD could be integrated into therapeutic strategies for metabolic disorders. 7. The conclusion is currently embedded within the discussion. Create a distinct conclusion section that succinctly restates the main findings, the potential clinical implications, and the next steps for research. This will help to underscore the importance of your work. 8. The choice of inflammatory markers (CRP, TNF-α, IL-6) is appropriate but limited. Including additional markers, such as IL-10 or IL-1β, could provide a more comprehensive picture of the inflammatory response and further substantiate the claims made regarding anti-inflammatory effects. 9. While the study shows that Lactobacillus plantarum KAD has beneficial effects, the mechanistic pathways are not thoroughly explored. The discussion would benefit from more detailed hypotheses or evidence about how the probiotic strain exerts its effects, particularly in relation to gut microbiota modulation and hepatic function. 10. The discussion sometimes overstates the significance of the findings without sufficient qualification. For example, the claims about the potential therapeutic benefits of Lactobacillus plantarum KAD should be tempered by acknowledging the limitations of extrapolating animal model results to human health outcomes. 11. The figures and tables are informative but may need more detailed legends. Ensure that each figure and table have a comprehensive legend that explains all abbreviations and provides enough context for understanding without referring to the text. Consider whether the figures could be reordered or combined to tell a clearer story. 12. The section on gut microbiota analysis could be expanded to include more details on the bioinformatics methods used. For example, the criteria for sequence quality control, taxonomy assignment, and the statistical methods used to compare the microbiota compositions between groups should be clearly stated. 13. The description of the histological scoring system is vague. It would be beneficial to provide more detailed criteria for the scoring of hepatic and colonic tissue damage, as well as examples or references to standard protocols. 14. Many grammatical errors in the text throughout the manuscript were understandable. Thus, the language of the paper should be checked carefully again. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: This study investigates the potential of Lactobacillus plantarum KAD supplementation to mitigate metabolic disorders, particularly in the context of high-fat diet (HFD)-induced insulin resistance (IR) and associated hepatic injuries in mice. The manuscript has several promising aspects, but it requires revisions as several points need to be carefully revised before the next resubmission as follows: 1) Clarify the hypothesis of the study at the end of the Introduction section. 2) How did you calculate the sample size for the animals included in this study? 3) What is dose of L. plantarum per kg diet? 4) The authors had to justify the selection of L. plantarum dose, supported by appropriate reference. 5) In the Results section, remove the data from the text as it is already displayed in Figures. 6) The formulation or nutrient composition of the experimental diet should be given. 7) English editing of the manuscript is highly recommended. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Lactobacillus plantarum KAD protects against High-Fat Diet-Induced Hepatic Complications in Swiss Albino Mice: Role of Inflammation and Gut Integrity PONE-D-24-27060R1 Dear Dr. Saha, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ahmed Khalafallah Sadeq Rashwan, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): Dear Dr. Tilak Saha and Co-authors, We are pleased to inform you that your manuscript titled “Lactobacillus plantarum KAD Protects against High-Fat Diet-Induced Hepatic Complications in Swiss Albino Mice: Role of Inflammation and Gut Integrity” has been accepted for publication in PLOS ONE. The reviewers and editors commend the thorough research and insightful findings you have presented. Your study provides important contributions to our understanding of gut microbiota’s role in mitigating hepatic complications associated with high-fat diets, particularly through the mechanisms of inflammation and gut integrity. This work holds significant implications for future research in microbiome therapy and metabolic health. We appreciate the time and effort you invested in addressing all comments and suggestions provided by our reviewers. Your diligent revisions have further strengthened the clarity and impact of the study. Please ensure that all final revisions, if any, are submitted in a timely manner for the next steps in the publication process. We look forward to seeing your work reach the scientific community and inspire further research in this promising area. Thank you for choosing PLOS ONE as the platform to publish your work. Reviewers' comments: |
| Formally Accepted |
|
PONE-D-24-27060R1 PLOS ONE Dear Dr. Saha, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Ahmed Khalafallah Sadeq Rashwan Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .